Quinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-κB, and cell-cycle progression in non-small cell lung cancer
about
Repurposing the anti-malarial drug, quinacrine: new anti-colitis propertiesProtective effect of quinacrine against glycerol-induced acute kidney injury in rats.Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth.SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.Evodiamine induces apoptosis and enhances apoptotic effects of erlotinib in wild-type EGFR NSCLC cells via S6K1-mediated Mcl-1 inhibition.Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical ModelsSSRP1 silencing inhibits the proliferation and malignancy of human glioma cells via the MAPK signaling pathway.Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer.Quinacrine Inhibits ICAM-1 Transcription by Blocking DNA Binding of the NF-κB Subunit p65 and Sensitizes Human Lung Adenocarcinoma A549 Cells to TNF-α and the Fas Ligand.Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer.
P2860
Q28817699-8554A73B-3DCB-4E1A-91F6-8EBB09A434A6Q36262805-8D80377B-E445-411C-AA71-2B0B060654DFQ36546665-5DD1BC2F-B1FF-4AAF-8A33-F42099655C63Q36939787-6634B829-0309-4306-9247-9A8BCBC18131Q37664869-E49DB89A-215C-4D41-A8F5-D8593B15C924Q38360827-333726D6-83FF-4BCE-B8E2-9B9C700FD972Q38804415-6A1FB969-2064-42DB-80EF-BFEAD8275408Q42775850-931C42F9-452D-4EEC-900B-75766D623046Q47629853-39A2DCC0-D310-4D81-942F-A245981681E0Q47877975-69FC85F0-0D66-4293-A29F-CA75A93BAFACQ48174470-C6CDE104-7DB5-41CD-BF3A-308CF6723D9FQ50148114-23C67AB1-8837-429A-8D7E-3C74304A956D
P2860
Quinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-κB, and cell-cycle progression in non-small cell lung cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Quinacrine overcomes resistanc ...... in non-small cell lung cancer
@ast
Quinacrine overcomes resistanc ...... in non-small cell lung cancer
@en
Quinacrine overcomes resistanc ...... in non-small cell lung cancer
@nl
type
label
Quinacrine overcomes resistanc ...... in non-small cell lung cancer
@ast
Quinacrine overcomes resistanc ...... in non-small cell lung cancer
@en
Quinacrine overcomes resistanc ...... in non-small cell lung cancer
@nl
prefLabel
Quinacrine overcomes resistanc ...... in non-small cell lung cancer
@ast
Quinacrine overcomes resistanc ...... in non-small cell lung cancer
@en
Quinacrine overcomes resistanc ...... in non-small cell lung cancer
@nl
P2093
P2860
P1476
Quinacrine overcomes resistanc ...... in non-small cell lung cancer
@en
P2093
Afshin Dowlati
George R Stark
Josephine Kam Tai Dermawan
Katerina Gurova
Neelesh Sharma
Sarmishtha De
P2860
P304
P356
10.1158/1535-7163.MCT-14-0013
P577
2014-07-15T00:00:00Z